Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 50228-452, ATORVASTATIN CALCIUM, tablet, film coated, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-452
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205519
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
50228-452-0550228045205500 TABLET, FILM COATED in 1 BOTTLE (50228-452-05)
50228-452-905022804529090 TABLET, FILM COATED in 1 BOTTLE (50228-452-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f2d8b5e9-6ff2-4efa-ab01-e13df29f7371
  • NADAC price for package 50228045205

    GET /v1/drugs/nadac/50228045205
  • NADAC price for package 50228045290

    GET /v1/drugs/nadac/50228045290

Use it

Look up 50228-452 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.